What happened
Adbiotech updated the terms of convertible bonds to raise US$9.11M, about 21.2% of its market value.
For context, this raise equals about 21.2% of the company's market value, which is the rough scale of potential new-share dilution.
| Instrument | Convertible bonds |
|---|---|
| Raise amount | US$9.11M |
| vs. market value | 21.2% |
| Filed | 2026-04-10, [Amended] Material event report (rights offering) |
| Source | DART rcept 20260410003159 → open original filing |
Source: DART. Information only, not investment advice.